Mode
Text Size
Log in / Sign up
N/A N=20 Randomized Single-blind Treatment

Bipolar Intervention Study: Cognitive Interpersonal Therapy

Mania · Hypomania · Bipolar Affective Disorder

Enrolled (actual)
20
Serious AEs
10.0%
Results posted
Jul 2014
Primary outcome: Primary: Montgomery Asberg Depression Rating Scale (MADRS) (Montogomery and Asberg, 1979) — 26.20; 20.20; 16.11; 15.22 units on a scale — p=0.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Cognitive Interpersonal Therapy (Other); Treatment As Usual (Other)
Age
Pediatric, Adult, Older Adult · 16+ yrs
Sex
All
Sponsor
NHS Greater Glasgow and Clyde
Primary completion
Oct 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Montgomery Asberg Depression Rating Scale (MADRS) (Montogomery and Asberg, 1979)
26.20; 20.20; 16.11; 15.22 0.05
PRIMARY
Bech-Rafaelsen Mania Rating Scale (BRMS) [Bech et al, 1979]
6.00; 6.70; 4.78; 4.11 0.996
SECONDARY
The Internal State Scale (ISS) (Bauer et al, 1991)
126.00; 78.00; 97.00; 181.00; 122.00; 114.00 <0.05 sig
SECONDARY
Global Assessment of Functioning (GAF)
57.90; 60.90; 72.00; 70.56 <0.05 sig

Summary

There is a need to develop a better understanding of the early phase of bipolar disorder, and to develop and evaluate effective psychosocial interventions that assist people in this phase. The purpose of this study is to determine whether or not it is feasible to conduct a larger study of the effectiveness of cognitive interpersonal therapy (a psychological therapy) with individuals who have experienced their first or second treated episode of mania or hypomania (symptoms common in early development of bipolar disorders).

Eligibility Criteria

Inclusion Criteria

  • Eligible individuals will have experienced their first or second treated episode of mania and / or hypomania in the previous 12-months prior to study entry.

Exclusion Criteria

  • Participants will be excluded if there is a (1) diagnosis of learning disability; (2) inability to participate in psychotherapy/research due to acute medical condition or acute mania
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01315028). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search